First Horizon Advisors’s Chemed CHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $98.8K | Buy |
202
+29
| +17% | +$16.5K | ﹤0.01% | 719 |
|
|
2025
Q1 | $107K | Buy |
173
+24
| +16% | +$13.6K | ﹤0.01% | 668 |
|
|
2024
Q4 | $79.4K | Sell |
149
-20
| -12% | -$11.3K | ﹤0.01% | 765 |
|
|
2024
Q3 | $102K | Hold |
169
| – | – | ﹤0.01% | 721 |
|
|
2024
Q2 | $92.1K | Hold |
169
| – | – | ﹤0.01% | 712 |
|
|
2024
Q1 | $109K | Hold |
169
| – | – | ﹤0.01% | 666 |
|
|
2023
Q4 | $99.2K | Hold |
169
| – | – | ﹤0.01% | 665 |
|
|
2023
Q3 | $88.2K | Hold |
169
| – | – | ﹤0.01% | 660 |
|
|
2023
Q2 | $91.9K | Hold |
169
| – | – | ﹤0.01% | 681 |
|
|
2023
Q1 | $91.2K | Sell |
169
-13
| -7% | -$6.63K | ﹤0.01% | 674 |
|
|
2022
Q4 | $93.2K | Buy |
182
+10
| +6% | +$4.87K | ﹤0.01% | 644 |
|
|
2022
Q3 | $74K | Sell |
172
-169
| -50% | -$81.3K | ﹤0.01% | 702 |
|
|
2022
Q2 | $159K | Buy |
341
+311
| +1,037% | +$152K | 0.01% | 517 |
|
|
2022
Q1 | $15K | Sell |
30
-28
| -48% | -$13.4K | ﹤0.01% | 971 |
|
|
2021
Q4 | $30K | Sell |
58
-4
| -6% | -$1.92K | ﹤0.01% | 1129 |
|
|
2021
Q3 | $28K | Hold |
62
| – | – | ﹤0.01% | 1145 |
|
|
2021
Q2 | $28K | Sell |
62
-12
| -16% | -$5.76K | ﹤0.01% | 985 |
|
|
2021
Q1 | $33K | Buy |
74
+4
| +6% | +$1.96K | ﹤0.01% | 887 |
|
|
2020
Q4 | $37K | Hold |
70
| – | – | ﹤0.01% | 692 |
|
|
2020
Q3 | $33K | Sell |
70
-10
| -13% | -$4.91K | ﹤0.01% | 657 |
|
|
2020
Q2 | $36K | Sell |
80
-20
| -20% | -$8.93K | ﹤0.01% | 607 |
|
|
2020
Q1 | $43K | Hold |
100
| – | – | ﹤0.01% | 513 |
|
|
2019
Q4 | $44K | Buy |
100
+15
| +18% | +$6.31K | ﹤0.01% | 599 |
|
|
2019
Q3 | $35K | Buy |
85
+15
| +21% | +$6.12K | ﹤0.01% | 646 |
|
|
2019
Q2 | $25K | Sell |
70
-19
| -21% | -$6.35K | ﹤0.01% | 793 |
|
|
2019
Q1 | $28K | Hold |
89
| – | – | ﹤0.01% | 693 |
|
|
2018
Q4 | $25K | Hold |
89
| – | – | ﹤0.01% | 704 |
|
|
2018
Q3 | $28K | Hold |
89
| – | – | ﹤0.01% | 754 |
|
|
2018
Q2 | $28K | Hold |
89
| – | – | ﹤0.01% | 769 |
|
|
2018
Q1 | $25K | Hold |
89
| – | – | ﹤0.01% | 711 |
|
|
2017
Q4 | $23K | Buy |
89
+34
| +62% | +$7.72K | ﹤0.01% | 779 |
|
|
2017
Q3 | $11K | Hold |
55
| – | – | ﹤0.01% | 958 |
|
|
2017
Q2 | $10K | Hold |
55
| – | – | ﹤0.01% | 969 |
|
|
2017
Q1 | $11K | Buy |
55
+1
| +2% | +$174 | ﹤0.01% | 980 |
|
|
2016
Q4 | $7K | Hold |
54
| – | – | ﹤0.01% | 1079 |
|
|
2016
Q3 | $7K | Hold |
54
| – | – | ﹤0.01% | 1069 |
|
|
2016
Q2 | $7K | Hold |
54
| – | – | ﹤0.01% | 1040 |
|
|
2016
Q1 | $7K | Hold |
54
| – | – | ﹤0.01% | 1068 |
|
|
2015
Q4 | $8K | Buy |
54
+4
| +8% | +$591 | ﹤0.01% | 958 |
|
|
2015
Q3 | $6K | Hold |
50
| – | – | ﹤0.01% | 1118 |
|
|
2015
Q2 | $6K | Sell |
50
-32
| -39% | -$3.96K | ﹤0.01% | 1160 |
|
|
2015
Q1 | $9K | Hold |
82
| – | – | ﹤0.01% | 1069 |
|
|
2014
Q4 | $8K | Sell |
82
-20
| -20% | -$2.11K | ﹤0.01% | 1101 |
|
|
2014
Q3 | $10K | Sell |
102
-54
| -35% | -$5.47K | ﹤0.01% | 1062 |
|
|
2014
Q2 | $15K | Buy |
156
+139
| +818% | +$12.3K | ﹤0.01% | 917 |
|
|
2014
Q1 | $1K | Buy |
+17
| New | +$1.39K | ﹤0.01% | 1278 |
|
Other funds holding CHE
First Horizon Advisors's CHE Position: Q2 2025 in Review
First Horizon Advisors increased its Chemed (CHE) stake by 17% in Q2 2025, buying an estimated $16.5K and bringing the position to 202 shares worth $98.8K. The position accounts for ﹤0.01% of the portfolio, ranked #719.
First Horizon Advisors first reported a position in CHE in Q1 2014 and has held it in 46 quarters since. The position peaked at $159K in Q2 2022. 538 funds tracked by Wall St. Rank hold CHE as of Q2 2025.
- First Horizon Advisors held 202 shares of Chemed worth $98.8K as of Q2 2025.
- First Horizon Advisors bought 29 Chemed shares in Q2 2025, an estimated $16.5K.
- Chemed made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #719 holding.
- First Horizon Advisors first reported a position in Chemed in Q1 2014 and has held it in 46 quarters since.
- First Horizon Advisors's Chemed position peaked at $159K in Q2 2022.
- 538 funds tracked by Wall St. Rank held Chemed as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.